TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation at the prestigious 2025 American Thoracic Society (ATS) International Conference. The...
Read More Details
Finally We wish PressBee provided you with enough information of ( SNS812, an innovative siRNA drug from Oneness and Microbio (Shanghai), selected for ATS 2025 oral presentation, demonstrating world-leading clinical outcomes in COVID-19 treatment )
Also on site :
- Lou Christie, “Lightnin’ Strikes” and “Rhapsody in the Rain” Singer, Dies at 82
- Legendary '80s Metal Band Performs Fan-Favorite for First Time in 20 Years: 'Sounding Great'
- Hundreds of Iranian Civilians Die in Israeli Strikes, Including a Poet and an Equestrian